Royal Philips has partnered with Allm to develop novel mobile diagnostic, acute and homecare products.

Philips has acquired a minority interest in Allm as part of the deal.

Allm’s mobile communications solutions will be integrated with Philips’ emergency care and resuscitation solutions.

The partnership will enhance the digitisation of Philips’ emergency care product portfolio with Allm’s next-generation technologies and medical communications platforms. It will enable the two companies to improve the health management of patients.

Based in the Netherlands, Royal Philips is a technology company specialising in the areas of healthcare and lighting, while Allm is a medical communications platform company in Japan.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

HeartHero has entered an agreement to license VivaQuant MDSP’s cardiac arrhythmia detection technology.

HeartHero will employ the technology for the advancement of its portable Automated External Defibrillator (AED), which is used for the detection of life-threatening heart disorders.

"The integration of technologies will also reduce the gap between the patient and emergency medical services to improve the chances of survival in the patients."

VivaQuantMDSP’s technology will help improve the processing and analysis of ECG data by its state-of-the-art embedded algorithms of its ECG software.

The integration of technologies will also reduce the gap between the patient and emergency medical services (EMS) to improve the chances of survival in the patients.

HeartHero is a medical device start-up, while VivaQuant MDSP is a medical device company. Both companies are based in the US.

DJO has signed a deal to become the exclusive sales representative for the SirenMD’s sports team market.

SirenMD software compiles injury data of athletes and provides a comprehensive report to the conference and member institutions. It offers a more integrated, compliant and efficient sharing of patients’ data.

DJO will provide a new and innovative care platform to existing customers and sales channels. It will enable SirenMD to provide improved care for athletes and sports teams.

DJO is a medical device company, while SirenMD is a technology platform company focussing on athlete health. The parties are based in the US.